An entrepreneur who has successfully exited radiology startups three times is once again betting on a technology capable of radically changing physicians' productivity. Michael Mardini is bringing Vware.ai out of stealth — a company commercializing Mass General Brigham's work on agentic artificial intelligence for radiology.
Mardini's track record includes Talk Technology, sold to Agfa in 2001, Commissure, acquired by Nuance in 2007, and National Decision Support Company, which went to Change Healthcare in 2018. Each time the focus was on tools that save radiologists time. Now he sees a similar leap from agentic AI that takes on routine tasks: loading patient data, analyzing coronary artery calcification, optimizing billing, and generating reports.
The technology underlying Composer IQ was born in the MGB AI unit under the leadership of Dr. Keith Dreyer. The platform not only allows hundreds of ready-made agents to be launched but also lets radiologists themselves, without programming skills, create new tools for their own needs. This lowers the barrier to adoption and solves the main problem — the complexity of IT infrastructure, which often slows down projects in hospitals.
From a financial standpoint, the story looks like a classic cycle: investment in niche expertise, rapid productivity growth, and a subsequent exit. With growing imaging volumes and staff shortages, every percentage point of radiologist time saved converts into real money — less overtime, more patients per specialist, higher clinic margins. Vware plans to sell Composer IQ directly and through partnerships with PACS and AI solution manufacturers.
Notably, Mardini is not simply moving academic development to the market but adapting it to commercial realities. The platform already works with hundreds of agents, and the company intends to discuss it at RSNA 2026. The question that concerns investors: will a fourth successful exit repeat itself, or will agentic AI prove more difficult than previous waves.
For clinics and investors in healthcare tech, this is a signal: money is flowing to where AI not only analyzes images but takes on the entire cycle of a physician's work. Those who adopt such tools before others will gain a competitive advantage in the form of lower costs and higher revenue. The rest risk being left with growing volumes and a stagnating staff.
Mardini's experience shows that in radiology, repeated success is built not on a single technology but on the ability to turn each new wave of automation into measurable time savings and capital.
